Correspondence 0001493152-23-029696 from enVVeno Medical Corp (NVNO)
enVVeno Medical Corp
Date: Aug. 21, 2023 · CIK: 0001661053 · Accession: 0001493152-23-029696
AI Filing Summary & Sentiment
File numbers found in text: 333-273546
Letter
VIA EDGAR Division of Corporation Finance Office of Life Sciences Re: enVVeno Medical Corporation Registration Statement on Form S-3 Filed July 31, 2023, as amended File No. 333-273546
Dear Ms. Park:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, enVVeno Medical Corporation, hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 4:30 p.m. EST on Wednesday, August 23, 2023, or as soon as thereafter practicable.
Very
truly yours,
/s/
Robert Berman
Show Raw Text
CORRESP
1
filename1.htm
ENVVENO
MEDICAL CORPORATION
70
Doppler
Irvine,
California 92618
August
21, 2023
VIA
EDGAR
U.S.
Securities and Exchange Commission
Division
of Corporation Finance
Office
of Life Sciences
100
F Street, N.E.
Washington,
DC 20549
Attn:
Jane Park
Re:
enVVeno
Medical Corporation
Registration
Statement on Form S-3
Filed
July 31, 2023, as amended
File
No. 333-273546
Dear
Ms. Park:
Pursuant
to Rule 461 under the Securities Act of 1933, as amended, enVVeno Medical Corporation, hereby requests acceleration of effectiveness
of the above referenced Registration Statement so that it will become effective at 4:30 p.m. EST on Wednesday, August 23, 2023, or as
soon as thereafter practicable.
Very
truly yours,
/s/
Robert Berman
Robert
Berman
Chief
Executive Officer
cc:
Ellenoff
Grossman & Schole LLP